Synthesis, anticandidal activity and cytotoxicity of some tetrazole derivatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 29, Issue 1, 2014, Pages 43-48

  Kaplancikli, Zafer Asim ^a   Yurttaş, Leyla ^a   Özdemir, Ahmet ^a   Turan Zitouni, Gülhan ^a   Işcan, Gökalp ^a   Akalin, Gülşen ^a   Abu Mohsen, Usama ^b  

^a ANADOLU UNIVERSITY   (Turkey)

^b AL AZHAR UNIVERSITY   (Palestine)

Author keywords

Anticandidal activity; Azole; Cytotoxicity; Tetrazole

Indexed keywords

1 (2,4 DICHLOROPHENYL) 2 [(1 METHYL 1H TETRAZOL 5 YL)THIO]ETHANONE; 1 (2,5 DICHLOROPHENYL) 2 [(1 METHYL 1H TETRAZOL 5 YL)THIO]ETHANONE; 1 (4 BROMOPHENYL) 2 [(1 METHYL 1H TETRAZOL 5 YL)THIO]ETHANONE; 3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; KETOCONAZOLE; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CARBON NUCLEAR MAGNETIC RESONANCE; CELL STRAIN 3T3; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ANIMALS; CANDIDA; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICROBIAL SENSITIVITY TESTS; NIH 3T3 CELLS; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT; TETRAZOLES;

EID: 84893497794     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.752363     Document Type: Article

References (46)

1. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of candidiasis. Clin Infect Dis 2004;38:161-89
2. Rees JR, Pinner RW, Hajjeh RA. The epidemiological features of invasive mycotic infections in the San Francisco bay area, 1992-1993: Results of population-based laboratory active surveillance. Clin Infect Dis 1998;27:1138-47
3. Polak A. The past, present and future of antimycotic combination therapy. Mycoses 1999;42:355-70
4. Fostel JM, Lartey PA. Emerging novel antifungal agents. Drug Discov Today 2000;5:25-32
5. Bodey GP. Azole antifungal agents. Clin Infect Dis 1992;14:161-9
6. Sheehan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clin Microbiol Rev 1999;12:40-79
7. Maertens JA. History of the development of azole derivatives. Clin Microbiol Infect 2004;10:1-9
8. Rossello A, Bertini S, Lapucci A, et al. Synthesis, antifungal activity, and molecular modeling studies of new inverted oxime ethers of oxiconazole. J Med Chem 2002;45:4903-12
9. Rajasekaran A, Thampi PP. Synthesis and analgesic evaluation of some 5-[b-(10-phenothiazinyl)ethyl]-1-(acyl)-1,2,3,4-Tetrazoles. Eur J Med Chem 2004;39:273-9
10. Dhayanithi V, Syed SS, Kumaran K, et al. Synthesis of selected 5-Thio-substituted tetrazole derivatives and evaluation of their antibacterial and antifungal activities. J Serb Chem Soc 2011; 76:165-75
11. Kraft A, Osterod F, Frohlich R. Bidirectional association of branched noncovalent complexes of tetrazoles and 1,3,5-Tris(4,5-dihydroimidazol-2-yl) benzene in solution. J Org Chem 1999; 64:6425-33
12. Klaubert DH, Sellstedt JH, Guinosso CJ, et al. 5-Tetrazolecarboxamides and their salts: New orally active antiallergy agents. J Med Chem 1981;24:748-52
13. El-Sayed WA, Megeid REA, Abbas HS. Synthesis and antimicrobial activity of new 1-[(tetrazol-5-yl)methyl]indole derivatives, their 1,2,4-Triazole thioglycosides and acyclic analogs. Arch Pharm Res 2011;34:1085-96
14. Sabbah M, Fontaine F, Grand L, et al. Synthesis and biological evaluation of new N-Acyl-homoserine-lactone analogues, based on triazole and tetrazole scaffolds, acting as LuxR-dependent quorum sensing modulators. Bioorg Med Chem 2012;20:4727-36
15. Rostom SAF, Ashour HMA, Abd El Razik HA, et al. Azole antimicrobial pharmacophore-based tetrazoles: Synthesis and biological evaluation as potential antimicrobial and anticonvulsant agents. Bioorg Med Chem 2009;17:2410-22
16. Meanwell NA. Synopsis of some recent tactical application of bioisosteres in drug design. J Med Chem 2011;54:2529-91
17. Myznikov LV, Hrabalek A, Koldobskii GI. Drugs in the tetrazole series. Chem Heterocycl Comp 2007;43:1-9
18. Adamec J, Waisser K, Kunes J, Kaustova J. A note on the antitubercular activities of 1-Aryl-5-benzylsulfanyltetrazoles. Arch Pharm 2005;338:385-9
19. Mohite PB, Pandhare RB, Khanage SG, Bhaskar VH. Synthesis and in vitro antimicrobial activity of some novel chalcones containing 5-phenyl tetrazole. Acta Pharma Sci 2010;52:505-10
20. Cosgrove CE, Laforge RA. Tetrazole derivatives I. Tetrazole alkamine ethers. J Org Chem 1956;21:197-200
21. Haydu SP, Bardley J, Hughes DTD. Inhibitory effect of oral doxantrazole on asthma induced by allergen inhalation. Br Med J 1975;3:283-4
22. Toney JH, Fitzgerald PMD, Sharma NG, et al. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of bacteroides fragiris metallo-b-lactamase. Chem Biol 1998; 5:185-96
23. Berghmans S, Hunt J, Roach A, Goldsmith P. Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants. Epilepsy Res 2007;75:18-28
24. Khanage SG, Mohite PB, Pandhareb RB, Raju SA. Study of analgesic activity of novel 1,2,4-Triazole derivatives bearing pyrazole and tetrazole moiety. J Pharm Res 2011;4:3609-11
25. Maxwell JR, Wasdahl DA, Wolfson AC, Stenberg VI. Synthesis of 5-Aryl-2H-Tetrazoles, 5-Aryl-2H-Tetrazole-2-Acetic acids, and [(4-phenyl-5-Aryl-4H-1,2,4-Triazol-3-yl)thio]acetic acids as possible superoxide scavengers and antiinflammatory agents. J Med Chem 1984;27:1565-70
26. Bhaskar VH, Mohite PB. Synthesis, characterization and evaluation of anticancer activity of some tetrazole derivatives. J Optoelectron Biomed M 2010;2:249-59
27. Ueda I, Ishii K, Sinozaki K, Htanaka M. Antiulcer agents. II: Synthesis and gastric acid antisecretory activity of N-[3-{3-(piperidinomethyl) phenoxy}propyl]-4-(1-methyl-1H-Tetrazol-5-ylthio)butanamide and related compounds. Chem Pharm Bull 1991;39:1430-5
28. Bhaskar VH, Mohite PB. Synthesis analgesic, anti-inflammatory and antimicrobial activities of some 1-[5-(substituted phenyl)-4,5-dihydro-1H- pyrazol-3-yl]-5-phenyl-1H-Tetrazole. J Optoelectron Biomed M 2011;3:7-16
29. Singh H, Chawla AS, Kapoor VK, et al. Progress in medicinal chemistry. In: Ellis GP, West GB, eds. Medicinal chemistry of tetrazoles. Amsterdam: Elsevier/North Holland; 1980:151-73
30. Upadhayaya RS, Jain S, Sinha N, et al. Synthesis of novel substituted tetrazoles having antifungal activity. Eur J Med Chem 2004;39:579-92
31. Matysiak J, Niewiadomy A, Krajewska-Kulak E, Mäcik-Niewiadomy G. Synthesis of some 1-(2,4-dihydroxythiobenzoyl)imidazoles,-imidazolines and-Tetrazoles and their potent activity against Candida species. IL Farmaco 2003;58:455-61
32. Roh J, Vávrová K, Hrabálek A. Synthesis and functionalization of 5-substituted tetrazoles. Eur J Org Chem 2012;31:6101-18
33. Kanakaraju S, Prasanna B, Chandramouli GVP. An efficient one-pot three-component synthesis of novel sulfanyl tetrazoles using ionic liquids. J Chem 2013;2013:1-6
34. Segura-Cabrera A, Pérez MAR. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-Throughput virtual screening. Bioorg Med Chem Lett 2008;18:3152-7
35. Webster SP, Binnie M, McConnell KMM, et al. Modulation of 11b-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-Tetrazoles. Bioorg Med Chem Lett 2010;20:3265-71
36. Morita H, Takeda M, Yoshimura T, et al. Novel type elimination reactions of sulfoxides bearing several heteroaromatics: Trapping of sulfines with 2,3-dimethyl-1,3-butadiene. J Org Chem 1999; 64:6730-7
37. Webster SP, Seckl JR, Walker BR. 1,5-substituted-1h-Tetrazole 11beta-hydroxysteroid dehydrogenase type 1 inhibitors, Patent GB 2429975 A 20070314, UK; 2007
38. Hakonarson H, Gurney ME, Halapi E. Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype, Patent US 20060014165 A1 20060119, USA; 2006
39. Hakonarson H, Gurney ME, Halapi E. Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association related applications, Patent WO 2005007144 A2 20050127, USA; 2005
40. Hudkins RL, Mallamo JP, Hamano M, et al. Selected derivatives of K-252a, Patent US 6306849 B1 20011023, USA; 2001
41. Hudkins RL, Mallamo JP, Hamano M, et al. K-252 derivatives as protein kinase C inhibitors, their preparation and formulations containing them, Patent WO 9746565 A1 19971211, USA; 1997
42. Nishi T, Uno T, Koga Y, Chu GN. Tetrazole derivatives and antiulcer composition containing them, EP 240015 A2 19871007; 1987
43. Goldfarb DS. Method for altering the lifespan of eukaryotic organisms, US 20090163545 A1 20090625, USA; 2009
44. Koneman EW, Allen SD, Janda WM, et al. Color atlas and textbook of diagnostic microbiology, mycology. Philadelphia, PA: Lippincott-Williams and Wilkins; 1997:983-1057
45. Mossmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63
46. Keiser K, Johnson CC, Tipton DA. Cytotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J Endod 2000;26:288-91